US okays 1st drug to fight 'Jewish' breast cancer gene


Some Ashkenazi Jewish women who carry a particular BRCA-1 genetic mutation have a 65 percent chance of developing breast cancer. US regulators have approved the first drug aimed at women with advanced breast cancer caused by an inherited flawed gene, known as the "Jewish gene" because of its prevalence in Ashkenazi Jewish women.



from Biotech News